A tumor-suppressive role for RNF4 was discovered in acute promyelocytic leukemia (APL), in which the oncogenic driver is a fusion protein that combines the promyelocytic leukemia protein (PML) with RARα (PML-RARα). Here, PML is linked to neoplasm.